Summit Trail Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$997K Sell
14,010
-1,775
-11% -$140K 0.01% 930
2025
Q4
$1.29M Sell
15,785
-2,405
-13% -$187K 0.02% 664
2025
Q3
$1.37M Buy
18,190
+6,469
+55% +$482K 0.02% 659
2025
Q2
$868K Buy
11,721
+4,987
+74% +$347K 0.01% 534
2025
Q1
$544K Buy
6,734
+800
+13% +$68.8K 0.02% 244
2024
Q4
$464K Buy
5,934
+1,036
+21% +$88.1K 0.02% 231
2024
Q3
$460K Buy
4,898
+638
+15% +$53.6K 0.01% 416
2024
Q2
$332K Buy
4,260
+851
+25% +$69.4K 0.01% 459
2024
Q1
$310K Buy
+3,409
New +$284K 0.01% 448
2023
Q3
Sell
-2,668
Closed -$217K 557
2023
Q2
$217K Buy
+2,668
New +$213K 0.01% 466

Other funds holding GEHC

Summit Trail Advisors's GEHC Position: Q1 2026 in Review

Summit Trail Advisors reduced its GE HealthCare (GEHC) stake by 11% in Q1 2026, selling an estimated $140K and leaving 14,010 shares worth $997K. The position accounts for 0.01% of the portfolio, ranked #930.

Summit Trail Advisors first reported a position in GEHC in Q2 2023 and has held it in 10 quarters since. The position peaked at $1.37M in Q3 2025. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Summit Trail Advisors held 14,010 shares of GE HealthCare worth $997K as of Q1 2026.
  • Summit Trail Advisors sold 1,775 GE HealthCare shares in Q1 2026, an estimated $140K.
  • GE HealthCare made up 0.01% of Summit Trail Advisors's portfolio in Q1 2026, its #930 holding.
  • Summit Trail Advisors first reported a position in GE HealthCare in Q2 2023 and has held it in 10 quarters since.
  • Summit Trail Advisors's GE HealthCare position peaked at $1.37M in Q3 2025.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.